University of Alabama at Birmingham, IDS Pharmacy — Birmingham, Alabama

University of Alabama at Birmingham, IDS Pharmacy is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham, IDS Pharmacy has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: HER2 Positive Breast Cancer, Hormone Sensitive Prostate Cancer, Prostate Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham, IDS Pharmacy?

University of Alabama at Birmingham, IDS Pharmacy has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham, IDS Pharmacy conducted?

University of Alabama at Birmingham, IDS Pharmacy has 6 clinical trials on record, with 2 currently active. Their work covers HER2 Positive Breast Cancer, Hormone Sensitive Prostate Cancer, Prostate Cancer.

Is University of Alabama at Birmingham, IDS Pharmacy accredited by Crixeo Health?

University of Alabama at Birmingham, IDS Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham, IDS Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.